(Q37322237)

19 August 2017

1 reference

title

Classifying antipsychotic agents : need for new terminology (English)

1 reference

19 August 2017

2

Matcheri S Keshavan

1 reference

19 August 2017

Ripu D Jindal

1

1 reference

19 August 2017

publication date

1 January 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

22

1 reference

19 August 2017

issue

12

1 reference

19 August 2017

page(s)

1047-1059

1 reference

https://scigraph.springernature.com/pub.10.2165/0023210-200822120-00007

19 August 2017

exact match

0 references

cites work

The physiological role of 5-HT2A receptors in working memory

1 reference

12 December 2020

-759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment

1 reference

12 December 2020

Adverse effects of risperidone on spatial working memory in first-episode schizophrenia.

1 reference

12 December 2020

Identification of separable cognitive factors in schizophrenia

1 reference

12 December 2020

The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review

1 reference

12 December 2020

Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes

1 reference

12 December 2020

Histamine in the brain: beyond sleep and memory

1 reference

12 December 2020

A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo

1 reference

12 December 2020

Amoxapine as an atypical antipsychotic: a comparative study vs risperidone

1 reference

12 December 2020

Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient

1 reference

12 December 2020

A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia.

1 reference

12 December 2020

The history of clozapine

1 reference

12 December 2020

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies

1 reference

12 December 2020

Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study

1 reference

12 December 2020

Cognitive and functional effects of atypical antipsychotic medications

1 reference

12 December 2020

Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia.

1 reference

12 December 2020

Alpha1-adrenergic blockers: current usage considerations

1 reference

12 December 2020

Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics

1 reference

12 December 2020

Increased insulin secretion by muscarinic M1 and M3 receptor function from rat pancreatic islets in vitro

1 reference

12 December 2020

A sensitizing regimen of amphetamine impairs visual attention in the 5-choice serial reaction time test: reversal by a D1 receptor agonist injected into the medial prefrontal cortex.

1 reference

12 December 2020

Presidential Address, 1974. The more or less startling effects of weak prestimulation

1 reference

12 December 2020

Are the cognitive effects of atypical antipsychotics influenced by their affinity to 5HT-2A receptors?

1 reference

12 December 2020

Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison

1 reference

12 December 2020

Dopamine receptors and brain function.

1 reference

12 December 2020

Pharmacologic interactions between the muscarinic cholinergic and dopaminergic systems in the modulation of prepulse inhibition in rats

1 reference

12 December 2020

Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders.

1 reference

12 December 2020

Tuberoinfundibular dopamine neurons and the regulation of prolactin secretion

1 reference

12 December 2020

D1 and D2 dopamine receptor antagonists reverse prepulse inhibition deficits in an animal model of schizophrenia.

1 reference

12 December 2020

Interactions between histaminergic and cholinergic systems in learning and memory.

1 reference

12 December 2020

Atypical and Conventional Antipsychotic Drugs in Treatment-Naive First-Episode Schizophrenia: A 52-Week Randomized Trial of Clozapine Vs Chlorpromazine

1 reference

12 December 2020

Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine.

1 reference

12 December 2020

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

12 December 2020

A meta-analysis of the efficacy of second-generation antipsychotics

1 reference

12 December 2020

Adiposity and insulin sensitivity derived from intravenous glucose tolerance tests in antipsychotic-treated patients

1 reference

12 December 2020

Do D1/D2 interactions regulate prepulse inhibition in rats?

1 reference

12 December 2020

AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus

1 reference

12 December 2020

Serotonergic modulation of cholinergic function in the central nervous system: cognitive implications

1 reference

12 December 2020

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group

1 reference

12 December 2020

Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine

1 reference

12 December 2020

Increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine

1 reference

12 December 2020

Antihistaminic drugs increase feeding, while histidine suppresses feeding in rats

1 reference

12 December 2020

What are the functional consequences of neurocognitive deficits in schizophrenia?

1 reference

12 December 2020

Is amoxapine an atypical antipsychotic? Positron-emission tomography investigation of its dopamine2 and serotonin2 occupancy

1 reference

12 December 2020

Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene

1 reference

12 December 2020

Hemodynamic consequences of chronic parasympathetic blockade with a peripheral muscarinic antagonist

1 reference

12 December 2020

Improvement in fear memory by histamine-elicited ERK2 activation in hippocampal CA3 cells.

1 reference

12 December 2020

Antipsychotic drugs exacerbate impairment on a working memory task in first-episode schizophrenia

1 reference

12 December 2020

The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents.

1 reference

12 December 2020

Activation of dopamine D1 receptors enhances cholinergic transmission and social cognition: a parallel dialysis and behavioural study in rats.

1 reference

12 December 2020

Serotonin 5-ht2c receptor agonists: potential for the treatment of obesity

1 reference

12 December 2020

Critical role of M3 muscarinic receptor in insulin secretion: implications for psychopharmacology

1 reference

12 December 2020

Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study

1 reference

12 December 2020

Low heart rate variability is not caused by typical neuroleptics in schizophrenia patients.

1 reference

12 December 2020

Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients

1 reference

12 December 2020

Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol

1 reference

12 December 2020

Muscarinic and nicotinic receptors synergistically modulate working memory and attention in humans

1 reference

12 December 2020

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

1 reference

12 December 2020

Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.

1 reference

12 December 2020

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

12 December 2020

Central histaminergic system and cognition

1 reference

12 December 2020

Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: a pilot study.

1 reference

12 December 2020

Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia

1 reference

12 December 2020

A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book

1 reference

12 December 2020

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder

1 reference

12 December 2020

Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation

1 reference

12 December 2020

Endogenous histamine in the medial septum-diagonal band complex increases the release of acetylcholine from the hippocampus: a dual-probe microdialysis study in the freely moving rat.

1 reference

12 December 2020

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

12 December 2020

From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase

1 reference

12 December 2020

The effects of clozapine on cognitive functioning in schizophrenia

1 reference

12 December 2020

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

1 reference

12 December 2020

Antipsychotic clozapine inhibits the function of alpha7-nicotinic acetylcholine receptors.

1 reference

12 December 2020

Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function

1 reference

12 December 2020

Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials.

1 reference

12 December 2020

A model of anticholinergic activity of atypical antipsychotic medications

1 reference

12 December 2020

Effects of the novel antipsychotic agent 7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro -2(1H)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland

1 reference

12 December 2020

Mechanisms linking obesity to insulin resistance and type 2 diabetes

1 reference

12 December 2020

Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes

1 reference

12 December 2020

The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: a pharmacological analysis in rats

1 reference

12 December 2020

Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

1 reference

12 December 2020

Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene

1 reference

12 December 2020

Muscarinic mechanisms of antipsychotic atypicality

1 reference

12 December 2020

Anticholinergic drugs and physical function among frail elderly population.

1 reference

12 December 2020

Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol

1 reference

12 December 2020

First do no harm: managing antihistamine impairment in patients with allergic rhinitis.

1 reference

12 December 2020

Maintenance treatment of schizophrenia with risperidone or haloperidol: 2-year outcomes

1 reference

12 December 2020

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

1 reference

12 December 2020

Agonist diversity in 5-HT(2C) receptor-mediated weight control in rats

1 reference

12 December 2020

Histamine H1 receptor involvement in prepulse inhibition and memory function: relevance for the antipsychotic actions of clozapine

1 reference

12 December 2020

The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone

1 reference

12 December 2020

Ventral hippocampal alpha7 and alpha4beta2 nicotinic receptor blockade and clozapine effects on memory in female rats

1 reference

12 December 2020

Correlation between plasma clozapine concentration and heart rate variability in schizophrenic patients

1 reference

12 December 2020

The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine

1 reference

12 December 2020

Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study

1 reference

12 December 2020

Heart-rate variability (HRV) in the ECG trace of routine EEGs: fast monitoring for the anticholinergic effects of clozapine and olanzapine?

1 reference

12 December 2020

Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets: role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemia

1 reference

12 December 2020

Open forum: effectiveness versus efficacy of second-generation antipsychotics: haloperidol without anticholinergics as a comparator

1 reference

12 December 2020

Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile

1 reference

12 December 2020

Tardive dyskinesia: eliminated, forgotten, or overshadowed?

1 reference

12 December 2020

A 5-HT2C receptor promoter polymorphism (HTR2C - 759C/T) is associated with obesity in women, and with resistance to weight loss in heterozygotes

1 reference

12 December 2020

A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

1 reference

12 December 2020

Genetics of antipsychotic treatment emergent weight gain in schizophrenia

1 reference

12 December 2020

Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial

1 reference

12 December 2020

The history of clozapine and its emergence in the US market: a review and analysis

1 reference

12 December 2020

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

1 reference

12 December 2020

10.2165/0023210-200822120-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

19 August 2017

1003670992

0 references

1 reference